… Abstract: Oral anticoagulants(OACs) have been widely used in patients with atrial
fibrillation(AF) who have moderate or high risk of thromboembolism to reduce stroke and systemic …

… 目前,指南推荐将直接口服抗凝药(direct oral anticoagulants, DOACs)优先于维生素K拮抗剂(…
However, the use of oral anticoagulant (OAC) carries the risk of gastrointestinal bleeding …

… haemodialysis. The ain of our study was i) to demonstrate time dependence of ASA … bleeding
risk in uraemic patients and ii) to investigate the effect of haemodialysis on uraeic bleeding …

… oral anticoagulants (… bleeding due to the extremely low trough concentrations and extremely
high peak concentrations of rivaroxaban. This study presents the current progress through a …

… In contrast, patients undergoing hemodialysis anticoagulated with unfractionated heparin
experience higher rates of bleeding (16% vs. 6.6%) compared with those anticoagulated with …

… oral anticoagulants, while preventing thromboembolism, it may also increase the risk of
concurrent renal injury, and the use of oral … the current use of oral anticoagulants in patients with …

… blood clots by decreasing the production of several clotting … ), pregnancy (N = 0) and chronic
dialysis (N = 1) within 1-year … user, we excluded 907 patients with an oral anticoagulants …

… Warfarin, as a traditional oral anticoagulant, has been recognized for its … oral anticoagulants
(NOACs), mainly including thrombin inhibitor (dabigatran etexilate) and blood coagulation …

… oral anticoagulant (dabigatran). These clinical results of the five chapters provide evidence
for the potential use of fractional excretion of magnesium as a predictor of CKD progression, …

… antithrombotic treatments including non-vitamin K antagonist oral anticoagulant(NOAC) and
single antiplatelet therapy is effective, and the risk of bleeding is lower than that of vitamin K …